Last reviewed · How we verify

NCT03745482

The Impact of Unilateral Lumbar Mobilisations on Hamstring Strength and Failure Point of the Hamstring Nordic Exercise

Completed NA Last updated 10 March 2020
What this trial tests

NA trial testing Lumbar Mobilisations in Hamstring Injury in 24 participants. Completed in 10 January 2020.

Timeline
4 January 2019
Primary endpoint
8 September 2019
10 January 2020

Quick facts

Lead sponsorTeesside University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingquadruple
Primary purposetreatment
Enrollment24
Start date4 January 2019
Primary completion8 September 2019
Estimated completion10 January 2020
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

Teesside University

Who can join

Adults 18 to 40, any sex, with Hamstring Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to build on previous published work, which has indicated lumbar mobilisations have the ability to increase hamstring extensibility and decrease muscle activity. The primary aim of this project is investigate if lumbar mobilisations have an affect on the Nordic Hamstring exercise. Aim: To investigate the short-term effects L4 and L5 Unilateral Posterior Anterior (UPA) Mobilisations on the lumbar spine on the Nordic Hamstring Exercise. Measures will include hamstring peak torque, sEMG activity and knee angle at first rapid change in angular acceleration.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Lumbar Mobilisations

Trials testing the same drug.

Other recruiting trials for Hamstring Injury

Currently open trials in the same condition.

Other Teesside University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03745482.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing